WHITE PAPER
APAC perspective on Fostering Success in CNS Innovation
Why CNS innovators should feel empowered to stay the course
Mar 21, 2024
Download

Despite facing formidable and very real near-term obstacles, there are compelling reasons to remain optimistic about central nervous system (CNS) innovation. Across the Asia-Pacific (APAC) region, we witness promising developments characterized by a deeper understanding of these conditions and the identification of new drug targets.

In our whitepaper, we delve into the enablers of breakthrough CNS innovation, provide an updated perspective on the competitive landscape and market opportunities in the APAC region, and explore four cutting-edge areas of innovation: Alzheimer's disease, Parkinson's disease, psychedelics-derived therapeutics, and digital therapeutics.

Contact Us